The high-powered duo is teaming up to build and equip a $1 billion research facility in California. The pair, both titans of their respective industries, aren't typically seen as compatible businesses ...

SAN FRANCISCO, Jan 12 (Reuters) - Nvidia (NVDA.O), opens new tab and U.S. pharma giant Eli Lilly (LLY.N), opens new tab will spend $1 billion building a new joint research lab in the San Francisco Bay ...

Forbes contributors publish independent expert analyses and insights. Anisha Sircar is a journalist covering tech, finance and society. This voice experience is generated by AI. Learn more. This voice ...

Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon with biology through artificial-intelligence-powered drug development. The ...

Whether you’re looking for an unforgettable Valentine’s Day gift or something to add to your own stack, a tennis bracelet is a simple yet timeless investment piece. Going the lab-grown diamond route ...

AI chipmaker Nvidia (NVDA) and pharmaceutical giant Eli Lilly (LLY) on Monday announced that the two companies would jointly invest $1 billion to create a lab in San Francisco focused on using AI to ...

Millions of Americans have tried GLP-1s, but some people find that the weight-loss drugs have too many side effects, are expensive or just don’t work for them. Patients also have to deal with changes ...

ChatGPT is a lot simpler to use than you think, and there are many ways to make it work well for you. Amanda Smith is a freelance journalist and writer. She reports on culture, society, human interest ...

Acesulfame potassium is an artificial sweetener (also known as Ace-K). Artificial sweeteners have been controversial because of possible health risks. But some of these sugar substitutes offer you a ...